CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a US study comparing the efficacy and safety of BDA MDI [Budesonide/Albuterol Sulfate (BDA) metered dose inhaler (MDI)] with AS [Albuterol Su...
Phase 3
Columbus, Ohio, United States and 60 other locations
BID using a dry-powder inhaler at one dose level over a 12-week Treatment period in adult participants with uncontrolled moderate-to-severe asthma...
Phase 2
Columbus, Ohio, United States and 132 other locations
and formoterol fumarate metered dose inhaler relative to budesonide metered dose inhaler in adults and adolescents with inadequately controlled asthma...
Phase 3
Columbus, Ohio, United States and 139 other locations
variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...
Phase 3
Columbus, Ohio, United States and 444 other locations
the efficacy and safety of budesonide and formoterol fumarate metered dose inhaler in adults and adolescents with inadequately controlled asthma...
Phase 3
Columbus, Ohio, United States and 180 other locations
(MDI) containing propellant 1,1-difluoroethane (HFA-152a) or 1,1,1,2-tetrafluoroethane (HFA-134a) in participants aged 12 years and above with asthma...
Phase 3
Dublin, Ohio, United States and 83 other locations
omalizumabTo evaluate the effect of dupilumab on asthma control at Week 24 compared to omalizumabTo evaluate the safety of dupilumab and om...
Phase 4
Columbus, Ohio, United States and 94 other locations
The primary objective is to assess the safety and tolerability of TAB004 as monotherapy and in combination with toripalimab in subjects with selected...
Phase 1
Columbus, Ohio, United States and 23 other locations
Clinical trials
Research sites
Resources
Legal